1-4 of 4
Yu Kyeong Hwang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Pilot Study of MG4101, Allogeneic Natural Killer Cell, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sang A Kim, Youngil Koh, Miyoung Jung, Yu Kyeong Hwang, Ja Min Byun, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung-Soo Yoon
Journal: Blood
Blood (2021) 138 (Supplement 1): 3835.
https://doi.org/10.1182/blood-2021-152137
Published: 2021
Journal Articles

A Phase 1 Study of the Combination of MG4101, Ex Vivo -Expanded Allogeneic NK Cells and Rituximab for Relapsed or Refractory Non-Hodgkin Lymphoma

Dok Hyun Yoon, Youngil Koh, Heesook Park, Yu kyeong Hwang, Won Seog Kim
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-133518
Published: 2020
Journal Articles

Functional Characterization of Gamma Delta T Cells and Allogeneic Activated NK Cells As Effector Cells for Tafasitamab (MOR208)

Jung Hyun Her, Dominik Pretscher, Sungyoo Cho, Yu-Kyeong Hwang, Timm Hoeres, Rainer Boxhammer, Stefan Steidl, Maria Patra, Juergen Schanzer, Jan Endell
Journal: Blood
Blood (2019) 134 (Supplement_1): 3801.
https://doi.org/10.1182/blood-2019-128511
Published: 2019
Journal Articles

Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia

Clinical Trials & Observations
Jaewon Choi, Yu Kyeong Hwang, Ki Woong Sung, Soo Hyun Lee, Keon Hee Yoo, Hye Lim Jung, Hong Hoe Koo, Hee-Jin Kim, Hyong Jin Kang, Hee Young Shin, Hyo Seop Ahn
Journal: Blood
Blood (2006) 109 (2): 471–477.
https://doi.org/10.1182/blood-2006-07-032557
Published: 2006